Nicholas Chornet, the Senior Vice-President International at Moderna, is one of the key people leading to provide COVID-19 vaccines to Canada. Chornet moved from Quebec, Canada to Switzerland to set-up Moderna’s European office. He hasn’t seen his distant relatives for more than a year. He is spending his time to spearhead the development of the drug for COVID-19.
Moderna, a pharmaceutical company, is one of the major candidates to supply COVID-19 vaccines for Canada. According to the deals signed with Canada, there are 414 million doses of coronavirus vaccines from seven different manufacturers such as Pfizer, Moderna, Sanofi, Johnson & Johnson, Novavax, AstraZeneca and Medicago. The Moderna vaccines will be available by January in Canada.
“Canada is one of the countries that moved very, very fast in securing a vaccine with us. It’s one of the first countries or one of the top countries to receive our supply also,” Chornet told Global News.